Thiopental sodium is discontinued (DEA controlled substance). It is a barbiturate that is administered intravenously for the induction of general anesthesia or for the production of complete anesthesia of short duration. It is also used for hypnosis and for the control of convulsive states. It has been used in neurosurgical patients to reduce increased intracranial pressure. It does not produce any excitation but has poor analgesic and muscle relaxant properties. Small doses have been shown to be anti-analgesic and lower the pain threshold. References: Prabhakar H, Kalaivani M. Propofol versus thiopental sodium for the treatment of refractory status epilepticus. Cochrane Database Syst Rev. 2015 Jun 25;(6):CD009202. doi: 10.1002/14651858.CD009202.pub3. Review. Update in: Cochrane Database Syst Rev. 2017 Feb 03;2:CD009202. PubMed PMID: 26111021.

纯度：≥98%

CAS：71-73-8